Feline Sarcoma Oncogene (FES) (N-Term) Peptid
Kurzübersicht für Feline Sarcoma Oncogene (FES) (N-Term) Peptid (ABIN8100568)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- FES Peptide - N-terminal region
-
Sequenz
- EGMRKWMAQR VKSDREYAGL LHHMSLQDSG GQSRAISPDS PISQTHSQDI
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-FES Antibody (ARP54607_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- FES (Feline Sarcoma Oncogene (FES))
-
Hintergrund
-
Background Information: FES is the human cellular counterpart of a feline sarcoma retrovirus protein with transforming capabilities. FES has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Its chromosomal location has linked it to a specific translocation event identified in patients with acute promyelocytic leukemia but it is also involved in normal hematopoiesis.
Alternative Symbols: FPS
-
Molekulargewicht
- 84kDa
-
Gen-ID
- 2242
-
NCBI Accession
- NP_001137255
-
UniProt
- P07332
Target
-